On Monday, October 15, U.S. health regulators announced that two other drugs produced by the New England Compounding Center (NECC), of Framingham, Massachusetts, may be linked to the meningitis outbreak.   According to the Food and Drug Administration (FDA), there is an ongoing investigation of